Czy antagoniści receptorów angiotensynowych AT1 (sartany) mogą zwiększać ryzyko wystąpienia choroby nowotworowej? Komentarz kardiologa i hipertensjologa Commentary
Article Sidebar
Published:
Mar 30, 2012
Main Article Content
Abstract
None
Downloads
Download data is not yet available.
Metrics
Metrics Loading ...
Article Details
How to Cite
1.
Filipiak KJ. Czy antagoniści receptorów angiotensynowych AT1 (sartany) mogą zwiększać ryzyko wystąpienia choroby nowotworowej? Komentarz kardiologa i hipertensjologa. OncoReview [Internet]. 2012Mar.30 [cited 2024Nov.22];2(1(5):63-4. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/297
Issue
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)